General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0RSTHX
ADC Name
H1L2-Dxd
Synonyms
DS-6000a
   Click to Show/Hide
Organization
Daiichi Sankyo Company Limited
Drug Status
Investigative
Drug-to-Antibody Ratio
7-8
Structure
Antibody Name
undisclosed
Antigen Name
Cadherin-6 (CDH6)
 Antigen Info 
Payload Name
Undisclosed
Therapeutic Target
Stimulator of interferon genes protein (STING1)
 Target Info 
Linker Name
CN119255825A H1L2-Dxd Linker
 Linker Info 
Conjugate Type
Random conjugation through reduced inter-chain cysteines
General Information of The Activity Data Related to This ADC
Revealed Based on the Cell Line Data
Click To Hide/Show 3 Activity Data Related to This Level
Standard Type Value Units Cell Line Disease Model
Half Maximal inhibitory Concentration (lC50) 
> 100
nM
CVCL_1844
Adult acute myelomonocytic leukemia, Acute myelomonocytic leukemia
Half Maximal inhibitory Concentration (lC50) 
> 100
nM
CVCL_1632
Acute myeloid leukemia, Childhood acute myeloid leukemia
Half Maximal inhibitory Concentration (lC50) 
> 100
nM
CVCL_2161
Acute promyelocytic leukemia
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
Click To Hide/Show 3 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) > 100 nM High C10orf54 expression (C10orf54 +++)
Method Description
C1.18 DBM- (C6)-MMAF was tested in OCI/AML3,100-300nm,3days
In Vitro Model Adult acute myelomonocytic leukemia, Acute myelomonocytic leukemia OCI/AML3 cells CVCL_1844
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) > 100 nM High C10orf54 expression (C10orf54 +++)
Method Description
C1.18 DBM- (C6)-MMAF was tested in P31/FUJ,100-300nm,3days
In Vitro Model Acute myeloid leukemia, Childhood acute myeloid leukemia P31/FUJ cells CVCL_1632
Experiment 3 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) > 100 nM High C10orf54 expression (C10orf54 +++)
Method Description
C1.18 DBM- (C6)-MMAF was tested in PL21,100-300nm,3days
In Vitro Model Acute promyelocytic leukemia PL21 cells CVCL_2161
References
Ref 1 Anti-C10orf54 antibodies and uses thereof